Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Schwarz

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Biological Chemistry|March 10, 2010
High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptorsJohn McNeish, Marsha Roach, John Hambor, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2023
Brain-penetrant cyanoindane and cyanotetralin inhibitors of G2019S-LRRK2 kinase activityAlbert W Garofalo, Jacob Schwarz, Kerry Zobel, et al.
Journal of Medicinal Chemistry|January 23, 2026
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic DisordersMikhail Zibinsky, Delia Bradford, Dirk G Brockstedt, et al.
Global Advances in Integrative Medicine and Health|May 26, 2025
Feasibility, Acceptability and Modification of a Post-surgical Telehealth Mindfulness-Based Intervention to Enhance Recovery After Lumbar Spine Surgery: A Prospective Intervention StudyCarrie E Brintz, Erin Connors Kelly, Geneva Polser, et al.
Plos One|October 6, 2017
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumorsMark Merchant, John Moffat, Gabriele Schaefer, et al.
Journal of Medicinal Chemistry|November 13, 2013
Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiatorsNandini C Patel, Jacob Schwarz, Xinjun J Hou, et al.
Plos One|January 26, 2018
Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumorsMark Merchant, John Moffat, Gabriele Schaefer, et al.
Molecular Cancer Therapeutics|August 14, 2020
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity <i>In Vitro</i> and <i>In Vivo</i>Yamini M Ohol, Michael T Sun, Gene Cutler, et al.
Journal of Medicinal Chemistry|April 24, 2015
The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)Christopher L Shaffer, Nandini C Patel, Jacob Schwarz, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Biological Chemistry|March 10, 2010
High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptorsJohn McNeish, Marsha Roach, John Hambor, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2023
Brain-penetrant cyanoindane and cyanotetralin inhibitors of G2019S-LRRK2 kinase activityAlbert W Garofalo, Jacob Schwarz, Kerry Zobel, et al.
Journal of Medicinal Chemistry|January 23, 2026
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic DisordersMikhail Zibinsky, Delia Bradford, Dirk G Brockstedt, et al.
Global Advances in Integrative Medicine and Health|May 26, 2025
Feasibility, Acceptability and Modification of a Post-surgical Telehealth Mindfulness-Based Intervention to Enhance Recovery After Lumbar Spine Surgery: A Prospective Intervention StudyCarrie E Brintz, Erin Connors Kelly, Geneva Polser, et al.
Plos One|October 6, 2017
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumorsMark Merchant, John Moffat, Gabriele Schaefer, et al.
Journal of Medicinal Chemistry|November 13, 2013
Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiatorsNandini C Patel, Jacob Schwarz, Xinjun J Hou, et al.
Plos One|January 26, 2018
Correction: Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumorsMark Merchant, John Moffat, Gabriele Schaefer, et al.
Molecular Cancer Therapeutics|August 14, 2020
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity <i>In Vitro</i> and <i>In Vivo</i>Yamini M Ohol, Michael T Sun, Gene Cutler, et al.
Journal of Medicinal Chemistry|April 24, 2015
The discovery and characterization of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiator N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)Christopher L Shaffer, Nandini C Patel, Jacob Schwarz, et al.
Pageof 2